SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
36
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Platinum Pari-Mutuel Holdings Inc. (PPMH) and Lead Plaintiff Deadline: May 2, 2017

NEW YORK, March 09, 2017 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Platinum Pari-Mutuel Holdings Inc.  (“Platinum” or the “Company”) (OTCMKT:PPMH) and certain of its officers, and is on behalf of a class consisting of all persons or entities who purchased Platinum securities between July 12, 2016 and February 15, 2017, both dates inclusive (the “Class Period”). Such investors are advised to join this case by visiting the firm’s site: http://www.bgandg.com/ppmh .

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, and failed to disclose material adverse facts about the Company’s business, operations, and prospects.  Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Platinum’s press releases and financial information lacked validity; (2) Platinum’s disclosure controls and procedures were inadequate; and (3) consequently, Defendants’ public statements were materially false and misleading at all relevant times.

On February 16, 2017, the Securities and Exchange Commission (the SEC) suspended Platinum Pari-Mutuel securities from trading due to questions about the accuracy and adequacy of Platinum’s press releases, since at least July 2016, and the financial information Platinum provided to the public. The SEC specified that those questions regard the valuation of recent corporate acquisitions and forecasts for future revenues.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/ppmh  or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Platinum you have until May 2, 2017 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | info@bgandg.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ImmunoGenesis Showcases STING Agonist Progress at SITC

Updated Category News Views 113

STING Agonists: The Next Frontier in Glioblastoma Treatment? Out there in the weeds of immunotherapy, ImmunoGenesis is gearing up for its moment at the SITC 2026 Annual Meeting with its STING agonist, IMGS-203. The stakes are skyscraper-high as this novel treatment makes a play against recurrent glioblastoma (GBM)—one tough cookie in the realm of brain cancers....

Continue Reading
PeptideWorld Paves the Way for Innovative Peptide Education

Updated Category News Views 27

The Rise of Peptide Education Imagine you're wading through a bog of health trends. That's how it feels trying to get a grip on peptide therapies these days, right? Luckily, PeptideWorld, powered by e?vita Health, is here to toss you a lifeline. They're transforming the landscape with a mission to ditch the marketing mumbo-jumbo for hard science. Their pitch?...

Continue Reading
FIS Slashes Forecast: Guidance Under Scrutiny Now

Updated Category News Views 28

Rough Waves for FIS Shareholders If there’s one thing I've learned chewing on greasy bacon over the years, it's that nothing rattles a stock like sketchy numbers and shattered investor confidence. Fidelity National Information Services, or FIS, has just yanked the rug out from its own 2026 forecast, cutting adjusted earnings per share (EPS) to a range of $5.82 to $5.89....

Continue Reading
Basildon Build-to-Rent Marks Progress for Starlight

Updated Category News Views 81

Basildon's New Housing Beacon Nears Completion No two construction milestones are the same, and Starlight Investments sure knows how to make theirs count. Reaching the skies with their project 'The Mercantile' in Basildon, the company has announced topping out—a significant phase in their build-to-rent development saga. With the structural peak reached, we're talking...

Continue Reading
Bluevua Triumphs with Three BASA Awards Wins

Updated Category News Views 18

Bluevua Sweeps the 2026 BASA Awards Stacking accolades like old trading wins, Bluevua just clinched not one, not two, but three 2026 Best of America Small Business Awards (BASA Awards®). If that's not a feather in their cap, I don't know what is. For the uninitiated, these BASA nods are no small potatoes—they're like the Oscars for small businesses. Bluevua, known for...

Continue Reading
Satisfi Labs Secures Two AI Patents, Boosts Reach

Updated Category News Views 78

Paving the Future with Patents Ah, patents. Like stock dividends for the tech world—they don’t change everything outright but can signal some mighty good things ahead. This time around, it’s Satisfi Labs who are in the spotlight. They’ve bagged not one, but two shiny U.S. patents to bolster what they’re calling Satisfi Forward. Honestly, it sounds like a...

Continue Reading
Omnicom Media: A Titan in Media Management Unveiled

Updated Category News Views 156

Omnicom Media's Latest Triumph Omnicom Media (NYSE: OMC) just snagged the 'Leader' badge in the ruthless world of media management services, according to Forrester's new report. Picture a chess game where every move counts—Omnicom's been playing for years, and they're a grandmaster at this point. This isn't some pat on the back; it's recognition of a powerhouse...

Continue Reading
Young Storytellers Honored: Bridging Cultures Through Journalism

Updated Category News Views 11

Leaders of Tomorrow: Campus News Awards 2026 It's no small feat to look at a room full of young journalists and see the future of how stories will be told. But that's exactly what happened at the Campus News Awards 2026 in Shenzhen. Here, kids from Hong Kong, Macao, Taiwan, and Southeast Asia stood proudly with their certificates, ready to tackle the changing landscape of...

Continue Reading
New Story Appoints Drudge, Celebrates Workplace Recognition

Updated Category News Views 103

A Dual Milestone: Leadership and Recognition In an industry chock-full of buzzwords, New Story’s latest moves cut through the noise. They've just announced Adam Drudge as their new Chief People Officer, and wouldn't you know it, they've snagged their third straight Most Loved Workplace® recognition for 2026. When a special ed company starts making waves like this,...

Continue Reading
Crocs™ Gains C2C Circularity Gold for Classic Clogs

Updated Category News Views 125

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Arlo's New Floodlight Camera Enhances Security at Home and Beyond

Updated Category News Views 90

Introducing the Arlo Wired Floodlight Camera Arlo Technologies, Inc. (NYSE: ARLO), known for its leading smart home security solutions, has introduced an enhanced Wired Floodlight Camera. This innovative all-in-one DIY security solution builds on the company's successful line of wire-free floodlights, leveraging advanced technology to ensure that your outdoor spaces are...

Continue Reading
Bruce Berkowitz Sells Stake in St. Joe: Insights and Impacts

Updated Category News Views 121

Bruce Berkowitz's Significant Sell-Off of St. Joe Shares Recently, it was reported that BRUCE BERKOWITZ, a notable stakeholder of St. Joe (NYSE: JOE), executed a significant sell-off of his shares. According to a filing with the SEC, Berkowitz sold 71,900 shares at a total value of approximately $4.48 million. Such actions from insiders often draw the attention of...

Continue Reading
Yaamava' Resort & Casino Triumphs Again with Top Awards

Updated Category News Views 268

Yaamava' Resort & Casino Continues to Impress Critics and Guests Year after year, Yaamava' Resort & Casino at San Manuel has made a remarkable mark in the gaming industry, consistently rising to the top of prestigious rankings. Most recently, the resort secured its status once again by being voted the Best Overall Casino Outside of Las Vegas and Best Native American...

Continue Reading
Maro Achieves $4.3 Million Seed Funding for Cybersecurity Innovation

Updated Category News Views 516

Maro Secures Significant Seed Funding to Combat Cybersecurity Risks Maro, an innovative player in cognitive security, has successfully raised $4.3 million from Downing Capital Group. This funding is set to empower companies to better manage human risks associated with cybersecurity, transforming the way organizations deal with elements such as social engineering, insider...

Continue Reading
Transforming Cancer Care: The Rise of B7-H3 Inhibitors

Updated Category News Views 246

Understanding B7-H3 Inhibitors and Their Impact on Cancer Treatment The B7-H3 inhibitors market is rapidly emerging as a transformative force in oncology. The significant increase in investment from pharmaceutical giants alongside a rising number of cancer diagnoses has heightened interest and research in this area. This class of inhibitors aims to target the B7-H3...

Continue Reading